首页 > 最新文献

Exploration of immunology最新文献

英文 中文
Trained-immunity and cross-reactivity for protection: insights from the coronavirus disease 2019 and monkeypox emergencies for vaccine development 经过训练的免疫力和交叉反应性保护:2019冠状病毒病和猴痘紧急情况对疫苗开发的见解
Pub Date : 2023-08-24 DOI: 10.37349/ei.2023.00102
A. Portilho, E. De Gaspari
The emergence and re-emergence of pathogens is a public-health concern, which has become more evident after the coronavirus disease 2019 (COVID-19) pandemic and the monkeypox outbreaks in early 2022. Given that vaccines are the more effective and affordable tools to control infectious diseases, the authors reviewed two heterologous effects of vaccines: the trained immunity and the cross-reactivity. Trained immunity, provided by attenuated vaccines, was exemplified in this article by the decreased the burden of COVID-19 in populations with high Bacille Calmette-Guerin (BCG) coverage. Cross-reactive responses were exemplified here by the studies which suggested that vaccinia could help controlling the monkeypox outbreak, because of common epitopes shared by orthopoxviruses. Although modern vaccination is likely to use subunit vaccines, the authors discussed how adjuvants might be the key to induce trained immunity and improve cross-reactive responses, ensuring that heterologous effects would improve the vaccine’s response.
病原体的出现和再出现是一个公共卫生问题,在2019年冠状病毒病(COVID-19)大流行和2022年初猴痘疫情爆发后,这一问题变得更加明显。鉴于疫苗是控制传染病的更有效和负担得起的工具,作者综述了疫苗的两种异源效应:训练免疫和交叉反应性。本文通过降低卡介苗(BCG)高覆盖率人群的COVID-19负担来证明减毒疫苗提供的训练免疫。交叉反应反应在这里的研究中得到了例证,这些研究表明痘苗可以帮助控制猴痘暴发,因为正痘病毒具有共同的表位。虽然现代疫苗接种可能使用亚单位疫苗,但作者讨论了佐剂如何可能是诱导训练免疫和改善交叉反应反应的关键,确保异源效应将改善疫苗的反应。
{"title":"Trained-immunity and cross-reactivity for protection: insights from the coronavirus disease 2019 and monkeypox emergencies for vaccine development","authors":"A. Portilho, E. De Gaspari","doi":"10.37349/ei.2023.00102","DOIUrl":"https://doi.org/10.37349/ei.2023.00102","url":null,"abstract":"The emergence and re-emergence of pathogens is a public-health concern, which has become more evident after the coronavirus disease 2019 (COVID-19) pandemic and the monkeypox outbreaks in early 2022. Given that vaccines are the more effective and affordable tools to control infectious diseases, the authors reviewed two heterologous effects of vaccines: the trained immunity and the cross-reactivity. Trained immunity, provided by attenuated vaccines, was exemplified in this article by the decreased the burden of COVID-19 in populations with high Bacille Calmette-Guerin (BCG) coverage. Cross-reactive responses were exemplified here by the studies which suggested that vaccinia could help controlling the monkeypox outbreak, because of common epitopes shared by orthopoxviruses. Although modern vaccination is likely to use subunit vaccines, the authors discussed how adjuvants might be the key to induce trained immunity and improve cross-reactive responses, ensuring that heterologous effects would improve the vaccine’s response.","PeriodicalId":93552,"journal":{"name":"Exploration of immunology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44793942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 induced ARDS: immunopathology and therapeutics 新冠肺炎诱导的ARDS:免疫病理学和治疗学
Pub Date : 2023-08-04 DOI: 10.37349/ei.2023.00101
Sneha Das, Tamanna Sharma, A. Bhardwaj, R. Srivastava
The coronavirus disease-2019 (COVID-19) pandemic is a significant threat in the modern era. Clinical studies show that the most common symptom of severe COVID-19 is viral pneumonia-induced acute respiratory distress syndrome (ARDS). The underlying mechanisms by which severe respiratory disease syndrome-coronavirus-2 (SARS-CoV-2) results in ARDS and how certain host factors confer an increased risk of developing severe disease remain unknown. Therefore, identifying the distinctive features of this severe and fatal disease and the therapeutic approaches to COVID-19-induced ARDS remains an immediate need to serve as a basis for best practice models of standardized ARDS treatment. This review article aims to comprehensively discuss the immunopathology of ARDS and provides an overview of the precise role of both the innate and adaptive immune system, with emphasis on the current treatment strategies being tested in the COVID-19-induced ARDS patients. This knowledge will supposedly help in revealing further mechanistic insights into understanding COVID-19-induced ARDS.
2019冠状病毒病(新冠肺炎)大流行是现代的一个重大威胁。临床研究表明,严重新冠肺炎最常见的症状是病毒性肺炎诱导的急性呼吸窘迫综合征(ARDS)。严重呼吸道疾病综合征冠状病毒2型(SARS-CoV-2)导致ARDS的潜在机制以及某些宿主因素如何增加患严重疾病的风险仍然未知。因此,确定这种严重致命疾病的独特特征以及COVID-19诱导的ARDS的治疗方法仍然是作为标准化ARDS治疗最佳实践模型的基础的迫切需要。这篇综述文章旨在全面讨论ARDS的免疫病理学,并概述先天免疫系统和适应性免疫系统的确切作用,重点介绍目前在COVID-19诱导的ARDS患者中测试的治疗策略。据推测,这些知识将有助于揭示进一步的机制见解,以理解COVID-19诱导的ARDS。
{"title":"COVID-19 induced ARDS: immunopathology and therapeutics","authors":"Sneha Das, Tamanna Sharma, A. Bhardwaj, R. Srivastava","doi":"10.37349/ei.2023.00101","DOIUrl":"https://doi.org/10.37349/ei.2023.00101","url":null,"abstract":"The coronavirus disease-2019 (COVID-19) pandemic is a significant threat in the modern era. Clinical studies show that the most common symptom of severe COVID-19 is viral pneumonia-induced acute respiratory distress syndrome (ARDS). The underlying mechanisms by which severe respiratory disease syndrome-coronavirus-2 (SARS-CoV-2) results in ARDS and how certain host factors confer an increased risk of developing severe disease remain unknown. Therefore, identifying the distinctive features of this severe and fatal disease and the therapeutic approaches to COVID-19-induced ARDS remains an immediate need to serve as a basis for best practice models of standardized ARDS treatment. This review article aims to comprehensively discuss the immunopathology of ARDS and provides an overview of the precise role of both the innate and adaptive immune system, with emphasis on the current treatment strategies being tested in the COVID-19-induced ARDS patients. This knowledge will supposedly help in revealing further mechanistic insights into understanding COVID-19-induced ARDS.","PeriodicalId":93552,"journal":{"name":"Exploration of immunology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45974923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conformational and functional regulation of the chicken tumor virus number 10 (CT10) regulator of kinase II (CrkII) adaptor protein by cyclophilin A 亲环蛋白A对鸡肿瘤病毒10号(CT10)激酶II (CrkII)接头蛋白的构象和功能调控
Pub Date : 2023-06-30 DOI: 10.37349/ei.2023.00099
N. Isakov
The Src homology 2 (SH2) and SH3 domain-containing chicken tumor virus number 10 (CT10) regulator of kinase (Crk) adaptor proteins include three cellular members that serve as integral constituents of multiple receptor-linked signal transduction pathways. CrkI and CrkII are products of alternative RNA-splicing which is transcribed from a single gene, while Crk-like (CrkL), which is highly homologous to CrkII, is encoded by a different gene. Thanks to their modular structure, the Crk adaptor proteins can simultaneously interact with activated receptors and a wide range of effector molecules, and orchestrate the assembly of complexes containing enzymes and substrates at the receptor site. They are involved in the regulation of a large number of cellular processes which control cell growth, differentiation, transformation, and apoptosis. Cell activation-dependent tyrosine phosphorylation of CrkII and CrkL serves as a major posttranslational modification mechanism that introduces conformational changes in the proteins by promoting an intramolecular interaction between the phosphotyrosine and the self SH2 domain. The resulting conformational change induces downregulation of CrkII- and CrkL-dependent biological processes. A second type of posttranslational modification mechanism regulates the structure and function of the CrkII adaptor protein by immunophilin-mediated protein isomerization. Two of the most abundant immunophilins in T lymphocytes which function as peptidyl-prolyl cis-trans isomerases (PPIases), namely cyclophilin A (CypA) and FK506-binding proteins (FKBPs), can associate with CrkII and catalyze its reciprocal cis-trans isomerization. This mechanism is of special importance for the regulation of T lymphocyte functions and for T cell-mediated immune responses, since immunophilin inhibitors, such as cyclosporin A (CsA) and FK506, function as immunosuppressive drugs that can prevent allotransplanted graft rejection. The present manuscript focuses on selected functions of Crk adaptor proteins, predominantly in T lymphocytes, and reviews in more detail the current knowledge on the immunophilin-dependent regulation of the structure and function of the CrkII adaptor protein.
含有鸡肿瘤病毒10号(CT10)激酶调节因子(Crk)衔接蛋白的Src同源性2(SH2)和SH3结构域包括三个细胞成员,它们是多种受体连接的信号转导途径的组成部分。CrkI和CrkII是从单个基因转录的选择性RNA剪接的产物,而与CrkII高度同源的Crk样(CrkL)由不同的基因编码。由于其模块化结构,Crk衔接蛋白可以同时与激活的受体和广泛的效应分子相互作用,并在受体位点协调包含酶和底物的复合物的组装。它们参与调控大量细胞过程,控制细胞生长、分化、转化和凋亡。CrkII和CrkL的细胞活化依赖性酪氨酸磷酸化是一种主要的翻译后修饰机制,通过促进磷酸酪氨酸和自身SH2结构域之间的分子内相互作用,在蛋白质中引入构象变化。由此产生的构象变化诱导CrkII和CrkL依赖性生物过程的下调。第二种类型的翻译后修饰机制通过亲免疫蛋白介导的蛋白质异构化来调节CrkII衔接蛋白的结构和功能。T淋巴细胞中两种最丰富的亲免疫蛋白,即亲环蛋白A(CypA)和FK506结合蛋白(FKBPs),作为肽基脯氨酰顺反异构酶(PPIase),可以与CrkII结合并催化其相互顺反异构化。这一机制对T淋巴细胞功能的调节和T细胞介导的免疫反应具有特别重要的意义,因为亲免疫蛋白抑制剂,如环孢菌素A(CsA)和FK506,可作为免疫抑制药物,防止同种异体移植移植物排斥反应。本手稿主要关注Crk衔接蛋白的选定功能,主要在T淋巴细胞中,并更详细地综述了目前对CrkII衔接蛋白结构和功能的免疫亲蛋白依赖性调节的认识。
{"title":"Conformational and functional regulation of the chicken tumor virus number 10 (CT10) regulator of kinase II (CrkII) adaptor protein by cyclophilin A","authors":"N. Isakov","doi":"10.37349/ei.2023.00099","DOIUrl":"https://doi.org/10.37349/ei.2023.00099","url":null,"abstract":"The Src homology 2 (SH2) and SH3 domain-containing chicken tumor virus number 10 (CT10) regulator of kinase (Crk) adaptor proteins include three cellular members that serve as integral constituents of multiple receptor-linked signal transduction pathways. CrkI and CrkII are products of alternative RNA-splicing which is transcribed from a single gene, while Crk-like (CrkL), which is highly homologous to CrkII, is encoded by a different gene. Thanks to their modular structure, the Crk adaptor proteins can simultaneously interact with activated receptors and a wide range of effector molecules, and orchestrate the assembly of complexes containing enzymes and substrates at the receptor site. They are involved in the regulation of a large number of cellular processes which control cell growth, differentiation, transformation, and apoptosis. Cell activation-dependent tyrosine phosphorylation of CrkII and CrkL serves as a major posttranslational modification mechanism that introduces conformational changes in the proteins by promoting an intramolecular interaction between the phosphotyrosine and the self SH2 domain. The resulting conformational change induces downregulation of CrkII- and CrkL-dependent biological processes. A second type of posttranslational modification mechanism regulates the structure and function of the CrkII adaptor protein by immunophilin-mediated protein isomerization. Two of the most abundant immunophilins in T lymphocytes which function as peptidyl-prolyl cis-trans isomerases (PPIases), namely cyclophilin A (CypA) and FK506-binding proteins (FKBPs), can associate with CrkII and catalyze its reciprocal cis-trans isomerization. This mechanism is of special importance for the regulation of T lymphocyte functions and for T cell-mediated immune responses, since immunophilin inhibitors, such as cyclosporin A (CsA) and FK506, function as immunosuppressive drugs that can prevent allotransplanted graft rejection. The present manuscript focuses on selected functions of Crk adaptor proteins, predominantly in T lymphocytes, and reviews in more detail the current knowledge on the immunophilin-dependent regulation of the structure and function of the CrkII adaptor protein.","PeriodicalId":93552,"journal":{"name":"Exploration of immunology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46904934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune response: the Achilles’ heel of the stem cell-based regenerative therapies 免疫反应:干细胞再生疗法的致命弱点
Pub Date : 2023-06-30 DOI: 10.37349/ei.2023.00100
C. S. Oliveira, F. Tavaria
Besides trauma, several pathological conditions which directly affect the normal functioning of organs, require new therapeutic strategies to repair damaged or diseased tissues. Tissue regeneration is a complex and spatiotemporal process involving a plethora of cell types, including various immune cells and stem cells in a synchronized relationship. However, individual parameters, namely ageing, obesity, diabetes, and chronic conditions, have been intrinsically correlated with poor regenerative properties of adult tissues. While vast progress has been made regarding stem cell-based therapy to direct self-healing, the immune response is still the Achilles’ heel of such strategies. Whereas the role of effector immune cells has been well defined along the regenerative process, an understanding of the behavior of the main adult stem cells, namely mesenchymal stem cells (MSCs) and hematopoietic stem and progenitor cells (HSPCs), along the different phases of the regenerative process could clarify how these stem cells can be used to positively influence the immune response. In this scope, this review highlights the main interactions between these stem cells and immune cells during tissue repair, exploring the most important regenerative properties of stem cells and correlating them with the modulation of the immune response during tissue regeneration. Furthermore, the utmost strategies used to explore how the behavior and stem cell fate are affected by specific microenvironments and/or stimuli usually found during a regenerative process, are emphasized. This clarification may provide critical insight into the molecular mechanisms by which stem cells modulate the immune response in a positive feedback loop toward tissue repair.
除了创伤,一些直接影响器官正常功能的病理状况需要新的治疗策略来修复受损或患病的组织。组织再生是一个复杂的时空过程,涉及过多的细胞类型,包括各种同步关系的免疫细胞和干细胞。然而,个体参数,即衰老、肥胖、糖尿病和慢性病,与成人组织的不良再生特性有着内在的相关性。尽管在基于干细胞的直接自我修复治疗方面取得了巨大进展,但免疫反应仍然是这些策略的致命弱点。尽管效应免疫细胞在再生过程中的作用已经得到了很好的定义,但了解主要成体干细胞,即间充质干细胞(MSC)和造血干细胞和祖细胞(HSPCs)在再生过程的不同阶段的行为,可以阐明这些干细胞如何被用来积极影响免疫反应。在这一范围内,这篇综述强调了这些干细胞和免疫细胞在组织修复过程中的主要相互作用,探索了干细胞最重要的再生特性,并将其与组织再生过程中免疫反应的调节联系起来。此外,还强调了用于探索行为和干细胞命运如何受到再生过程中通常发现的特定微环境和/或刺激的影响的最大策略。这一澄清可能为干细胞在组织修复的正反馈回路中调节免疫反应的分子机制提供关键的见解。
{"title":"Immune response: the Achilles’ heel of the stem cell-based regenerative therapies","authors":"C. S. Oliveira, F. Tavaria","doi":"10.37349/ei.2023.00100","DOIUrl":"https://doi.org/10.37349/ei.2023.00100","url":null,"abstract":"Besides trauma, several pathological conditions which directly affect the normal functioning of organs, require new therapeutic strategies to repair damaged or diseased tissues. Tissue regeneration is a complex and spatiotemporal process involving a plethora of cell types, including various immune cells and stem cells in a synchronized relationship. However, individual parameters, namely ageing, obesity, diabetes, and chronic conditions, have been intrinsically correlated with poor regenerative properties of adult tissues. While vast progress has been made regarding stem cell-based therapy to direct self-healing, the immune response is still the Achilles’ heel of such strategies. Whereas the role of effector immune cells has been well defined along the regenerative process, an understanding of the behavior of the main adult stem cells, namely mesenchymal stem cells (MSCs) and hematopoietic stem and progenitor cells (HSPCs), along the different phases of the regenerative process could clarify how these stem cells can be used to positively influence the immune response. In this scope, this review highlights the main interactions between these stem cells and immune cells during tissue repair, exploring the most important regenerative properties of stem cells and correlating them with the modulation of the immune response during tissue regeneration. Furthermore, the utmost strategies used to explore how the behavior and stem cell fate are affected by specific microenvironments and/or stimuli usually found during a regenerative process, are emphasized. This clarification may provide critical insight into the molecular mechanisms by which stem cells modulate the immune response in a positive feedback loop toward tissue repair.","PeriodicalId":93552,"journal":{"name":"Exploration of immunology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46413122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The aging process and its relation to periodontal conditions 衰老过程及其与牙周状况的关系
Pub Date : 2023-06-30 DOI: 10.37349/ei.2023.00098
Pitu Wulandari
Periodontal tissue destruction can cause complaints for sufferers. Inflammatory conditions of the gingiva, bleeding gums, and even tooth loss are clinical features of the destruction of the periodontal tissues. Periodontitis is an inflammatory disease involving the periodontal tissues. The prevalence of periodontium destruction increases with aging. Changes in innate and adaptive immunity that occur in the elderly also play a role in the severity of periodontitis. “Inflammaging” is a chronic inflammatory state associated with old age in humans. Periodontitis contributes to inflammaging since periodontitis in the elderly is associated with increased markers of systemic inflammation. Age-related changes also affect neutrophil function, especially antimicrobial activity, so neutrophils may become more pathological. After infiltration into the tissue, neutrophils are equipped with several antimicrobial strategies to reduce the number of antigens. Phagocytosis is the ability of neutrophils to engulf and kill microbes, but neutrophil phagocytosis is weakened in the elderly. Age-related changes affecting neutrophils, macrophages, and T cells appear to promote pathogenic immune responses and contribute to the increased prevalence of periodontal disease in aging individuals. Proper regulation of the host immune response is critical in maintaining periodontal health. This paper aims to describe the aging process and its relation to periodontal conditions.
牙周组织破坏会引起患者的抱怨。牙龈炎症、牙龈出血,甚至牙齿脱落都是牙周组织破坏的临床特征。牙周炎是一种涉及牙周组织的炎症性疾病。牙周组织破坏的患病率随着年龄的增长而增加。老年人先天免疫和适应性免疫的变化也在牙周炎的严重程度中发挥作用。“炎症”是一种与人类老年相关的慢性炎症状态。牙周炎导致炎症,因为老年人牙周炎与全身炎症标志物增加有关。与年龄相关的变化也会影响中性粒细胞的功能,尤其是抗菌活性,因此中性粒细胞可能会变得更具病理性。中性粒细胞渗透到组织中后,配备了几种抗菌策略来减少抗原的数量。吞噬作用是中性粒细胞吞噬和杀死微生物的能力,但中性粒细胞的吞噬作用在老年人中减弱。影响中性粒细胞、巨噬细胞和T细胞的年龄相关变化似乎促进了致病性免疫反应,并导致老年人牙周病患病率增加。宿主免疫反应的适当调节对维持牙周健康至关重要。本文旨在描述衰老过程及其与牙周状况的关系。
{"title":"The aging process and its relation to periodontal conditions","authors":"Pitu Wulandari","doi":"10.37349/ei.2023.00098","DOIUrl":"https://doi.org/10.37349/ei.2023.00098","url":null,"abstract":"Periodontal tissue destruction can cause complaints for sufferers. Inflammatory conditions of the gingiva, bleeding gums, and even tooth loss are clinical features of the destruction of the periodontal tissues. Periodontitis is an inflammatory disease involving the periodontal tissues. The prevalence of periodontium destruction increases with aging. Changes in innate and adaptive immunity that occur in the elderly also play a role in the severity of periodontitis. “Inflammaging” is a chronic inflammatory state associated with old age in humans. Periodontitis contributes to inflammaging since periodontitis in the elderly is associated with increased markers of systemic inflammation. Age-related changes also affect neutrophil function, especially antimicrobial activity, so neutrophils may become more pathological. After infiltration into the tissue, neutrophils are equipped with several antimicrobial strategies to reduce the number of antigens. Phagocytosis is the ability of neutrophils to engulf and kill microbes, but neutrophil phagocytosis is weakened in the elderly. Age-related changes affecting neutrophils, macrophages, and T cells appear to promote pathogenic immune responses and contribute to the increased prevalence of periodontal disease in aging individuals. Proper regulation of the host immune response is critical in maintaining periodontal health. This paper aims to describe the aging process and its relation to periodontal conditions.","PeriodicalId":93552,"journal":{"name":"Exploration of immunology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47267283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of an adaptor protein human germinal center-associated lymphoma (HGAL) in cell signaling and lymphomagenesis 人类生发中心相关淋巴瘤(HGAL)衔接蛋白在细胞信号传导和淋巴成像中的作用
Pub Date : 2023-06-28 DOI: 10.37349/ei.2023.00097
Xiaoyu Jiang, I. Lossos
Human germinal center (GC)-associated lymphoma (HGAL) is a multi-domain adaptor protein expressed in GC B lymphocytes, T follicular helper (Tfh) cells and lymphomas derived from these cells. HGAL expression is an independent predictor of longer survival of diffuse large B-cell lymphoma (DLBCL) and classical Hodgkin’s lymphoma (HL) patients. HGAL regulates B cell receptor (BCR) signaling and immunological synapse formation by binding to either the downstream effectors [e.g., spleen tyrosine kinase (Syk)] or other signaling regulators [e.g., growth factor receptor-bound protein 2 (Grb2)]. HGAL regulates the cytoskeleton that reshapes B cell morphology during BCR signaling and cell motility by at least two molecular mechanisms: enhanced Ras homolog gene family member A (RhoA) signaling and inhibition of myosin-actin translocation. These effects on the cytoskeleton decrease lymphoma dissemination in animal models and contribute to decreased lymphoma dissemination in patients. The latter may contribute to the association of HGAL protein expression with longer survival of patients with DLBCL and HL tumors. The ability to regulate multiple and distinct functions simultaneously in B cells implies that the HGAL protein level is tightly regulated. It was demonstrated that HGAL can be regulated by PR/SET domain 1 (PRDM1)/B lymphocyte-induced maturation protein-1 (BLIMP1) and interleukin-4 (IL-4) at the transcription level, by microRNA-155 (miR-155) at the post-transcriptional level, and by F-box protein 10 (FBXO10) at the post-translational level. Constitutive enforced expression of HGAL at physiological levels leads to lymphoid hyperplasia and DLBCL in mice. Future studies need to focus on identifying HGAL interactome, dissecting its interaction network, and understanding HGAL spatiotemporal signaling in live cells in physiological conditions. Further, the recent demonstration of HGAL expression in Tfh cells requires the determination of its function in these cells. These studies will contribute to new insights into the biology of these cellular subsets and how immune dysregulation contributes to lymphomagenesis.
人生发中心(GC)相关淋巴瘤(HGAL)是一种多结构域衔接蛋白,表达于GC B淋巴细胞、T滤泡辅助细胞(Tfh)和源自这些细胞的淋巴瘤。HGAL表达是弥漫性大b细胞淋巴瘤(DLBCL)和经典霍奇金淋巴瘤(HL)患者生存时间延长的独立预测因子。HGAL通过与下游效应物[如脾酪氨酸激酶(Syk)]或其他信号调节物[如生长因子受体结合蛋白2 (Grb2)]结合,调节B细胞受体(BCR)信号传导和免疫突触的形成。HGAL通过至少两种分子机制调节BCR信号传导和细胞运动过程中重塑B细胞形态的细胞骨架:增强Ras同源基因家族成员A (RhoA)信号传导和抑制肌球蛋白-肌动蛋白易位。这些对细胞骨架的影响减少了动物模型中的淋巴瘤传播,并有助于减少患者的淋巴瘤传播。后者可能有助于HGAL蛋白表达与DLBCL和HL肿瘤患者更长的生存期相关。在B细胞中同时调节多种不同功能的能力表明HGAL蛋白水平受到严格调节。结果表明,HGAL可以在转录水平上受PR/SET结构域1 (PRDM1)/B淋巴细胞诱导成熟蛋白1 (BLIMP1)和白介素-4 (IL-4)的调控,在转录后水平上受microRNA-155 (miR-155)的调控,在翻译后水平上受F-box蛋白10 (FBXO10)的调控。HGAL在生理水平上的组成性强制表达导致小鼠淋巴样增生和大细胞淋巴瘤。未来的研究需要重点确定HGAL相互作用组,剖析其相互作用网络,了解生理条件下活细胞中HGAL的时空信号。此外,最近证明HGAL在Tfh细胞中的表达需要确定其在这些细胞中的功能。这些研究将有助于对这些细胞亚群的生物学以及免疫失调如何导致淋巴瘤发生提供新的见解。
{"title":"Role of an adaptor protein human germinal center-associated lymphoma (HGAL) in cell signaling and lymphomagenesis","authors":"Xiaoyu Jiang, I. Lossos","doi":"10.37349/ei.2023.00097","DOIUrl":"https://doi.org/10.37349/ei.2023.00097","url":null,"abstract":"Human germinal center (GC)-associated lymphoma (HGAL) is a multi-domain adaptor protein expressed in GC B lymphocytes, T follicular helper (Tfh) cells and lymphomas derived from these cells. HGAL expression is an independent predictor of longer survival of diffuse large B-cell lymphoma (DLBCL) and classical Hodgkin’s lymphoma (HL) patients. HGAL regulates B cell receptor (BCR) signaling and immunological synapse formation by binding to either the downstream effectors [e.g., spleen tyrosine kinase (Syk)] or other signaling regulators [e.g., growth factor receptor-bound protein 2 (Grb2)]. HGAL regulates the cytoskeleton that reshapes B cell morphology during BCR signaling and cell motility by at least two molecular mechanisms: enhanced Ras homolog gene family member A (RhoA) signaling and inhibition of myosin-actin translocation. These effects on the cytoskeleton decrease lymphoma dissemination in animal models and contribute to decreased lymphoma dissemination in patients. The latter may contribute to the association of HGAL protein expression with longer survival of patients with DLBCL and HL tumors. The ability to regulate multiple and distinct functions simultaneously in B cells implies that the HGAL protein level is tightly regulated. It was demonstrated that HGAL can be regulated by PR/SET domain 1 (PRDM1)/B lymphocyte-induced maturation protein-1 (BLIMP1) and interleukin-4 (IL-4) at the transcription level, by microRNA-155 (miR-155) at the post-transcriptional level, and by F-box protein 10 (FBXO10) at the post-translational level. Constitutive enforced expression of HGAL at physiological levels leads to lymphoid hyperplasia and DLBCL in mice. Future studies need to focus on identifying HGAL interactome, dissecting its interaction network, and understanding HGAL spatiotemporal signaling in live cells in physiological conditions. Further, the recent demonstration of HGAL expression in Tfh cells requires the determination of its function in these cells. These studies will contribute to new insights into the biology of these cellular subsets and how immune dysregulation contributes to lymphomagenesis.","PeriodicalId":93552,"journal":{"name":"Exploration of immunology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41920529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
STIM/Orai-mediated calcium entry elicits spontaneous TSLP overproduction in epidermal cells of atopic dermatitis mice STIM/ orai介导的钙进入引起特应性皮炎小鼠表皮细胞自发的TSLP过量产生
Pub Date : 2023-06-11 DOI: 10.37349/ei.2023.00096
M. Fujii, Shuhei Kobayashi, Ayane Ueda, Misaki Sakagami, R. Matsui, Yumeka Yamada, T. Nabe, S. Ohya
Aim: Atopic dermatitis (AD) is a pruritic, chronic inflammatory skin disease. Thymic stromal lymphopoietin (TSLP) is highly expressed in the epidermis of patients with AD and induces T helper 2 (Th2) immune responses and itching. Although the mechanism underlying the stimulus-induced TSLP production in normal keratinocytes has been intensively studied, whether the production capability of TSLP is naturally enhanced in epidermal cells in AD conditions remains unclear. Previous studies demonstrated that a deficiency of polyunsaturated fatty acid (PUFA) causes AD-like pruritic skin inflammation in special diet-fed hairless mice. The aim of the study was to examine the TSLP production capability of epidermal cells isolated from diet-induced AD mouse model and its mechanism.Methods: Epidermal cells were isolated from normal and AD mice and incubated under unstimulated culture conditions to assess spontaneous TSLP production. Messenger ribonucleic acid (mRNA) and protein levels of TSLP were determined by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA), respectively.Results: TSLP level was markedly increased in the skin of AD mice. When epidermal cells were isolated from AD mice and cultured without stimulation, Tslp gene expression was upregulated, and a large amount of TSLP protein was extracellularly released. Such TSLP overproduction was not observed in the epidermal cells of normal mice. TSLP overproduction in AD epidermal cells was almost completely inhibited by extracellular calcium chelation, interference with plasma membrane interaction of stromal interaction molecule 1 (STIM1), blockade of the calcium release-activated calcium (CRAC) channels Orai1 and Orai2, or treatment with a PUFA γ-linolenic acid (GLA).Conclusions: Epidermal cells isolated from AD mice can spontaneously produce TSLP through STIM/Orai-mediated calcium entry, and GLA may negatively regulate this TSLP production.
目的:特应性皮炎(AD)是一种瘙痒性慢性炎症性皮肤病。胸腺基质淋巴生成素(TSLP)在AD患者的表皮中高表达,并诱导T辅助2 (Th2)免疫反应和瘙痒。虽然在正常角质形成细胞中刺激诱导的TSLP产生的机制已经被深入研究,但在AD条件下表皮细胞中TSLP的产生能力是否会自然增强尚不清楚。先前的研究表明,缺乏多不饱和脂肪酸(PUFA)会导致特殊饮食喂养的无毛小鼠出现ad样瘙痒性皮肤炎症。本研究旨在探讨饮食诱导的AD小鼠表皮细胞产生TSLP的能力及其机制。方法:分别从正常小鼠和AD小鼠中分离表皮细胞,在无刺激培养条件下观察TSLP的自发生成。采用实时聚合酶链反应(PCR)和酶联免疫吸附试验(ELISA)分别检测TSLP信使核糖核酸(mRNA)和蛋白水平。结果:AD小鼠皮肤中TSLP水平明显升高。分离AD小鼠表皮细胞,无刺激培养时,Tslp基因表达上调,大量Tslp蛋白在细胞外释放。在正常小鼠的表皮细胞中没有观察到这种TSLP的过量产生。胞外钙螯合、干扰质膜间质相互作用分子1 (STIM1)、阻断钙释放活化钙(CRAC)通道Orai1和Orai2,或PUFA γ-亚麻酸(GLA)处理,几乎完全抑制AD表皮细胞中TSLP的过量产生。结论:AD小鼠表皮细胞可通过STIM/ orai介导的钙进入自发产生TSLP, GLA可能负向调节TSLP的产生。
{"title":"STIM/Orai-mediated calcium entry elicits spontaneous TSLP overproduction in epidermal cells of atopic dermatitis mice","authors":"M. Fujii, Shuhei Kobayashi, Ayane Ueda, Misaki Sakagami, R. Matsui, Yumeka Yamada, T. Nabe, S. Ohya","doi":"10.37349/ei.2023.00096","DOIUrl":"https://doi.org/10.37349/ei.2023.00096","url":null,"abstract":"Aim: Atopic dermatitis (AD) is a pruritic, chronic inflammatory skin disease. Thymic stromal lymphopoietin (TSLP) is highly expressed in the epidermis of patients with AD and induces T helper 2 (Th2) immune responses and itching. Although the mechanism underlying the stimulus-induced TSLP production in normal keratinocytes has been intensively studied, whether the production capability of TSLP is naturally enhanced in epidermal cells in AD conditions remains unclear. Previous studies demonstrated that a deficiency of polyunsaturated fatty acid (PUFA) causes AD-like pruritic skin inflammation in special diet-fed hairless mice. The aim of the study was to examine the TSLP production capability of epidermal cells isolated from diet-induced AD mouse model and its mechanism.\u0000Methods: Epidermal cells were isolated from normal and AD mice and incubated under unstimulated culture conditions to assess spontaneous TSLP production. Messenger ribonucleic acid (mRNA) and protein levels of TSLP were determined by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA), respectively.\u0000Results: TSLP level was markedly increased in the skin of AD mice. When epidermal cells were isolated from AD mice and cultured without stimulation, Tslp gene expression was upregulated, and a large amount of TSLP protein was extracellularly released. Such TSLP overproduction was not observed in the epidermal cells of normal mice. TSLP overproduction in AD epidermal cells was almost completely inhibited by extracellular calcium chelation, interference with plasma membrane interaction of stromal interaction molecule 1 (STIM1), blockade of the calcium release-activated calcium (CRAC) channels Orai1 and Orai2, or treatment with a PUFA γ-linolenic acid (GLA).\u0000Conclusions: Epidermal cells isolated from AD mice can spontaneously produce TSLP through STIM/Orai-mediated calcium entry, and GLA may negatively regulate this TSLP production.","PeriodicalId":93552,"journal":{"name":"Exploration of immunology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42654786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Vav1, a hematopoietic signal transduction molecule, as an adaptor protein in health and disease Vav1,一种造血信号转导分子,作为一种衔接蛋白在健康和疾病中的作用
Pub Date : 2023-04-28 DOI: 10.37349/ei.2023.00095
S. Katzav
The growth and differentiation of normal cells are controlled by protein-tyrosine kinases, which serve as receptors for a wide variety of external signals. Small protein modules called Src homology 2 (SH2) and SH3 domains mediate protein-protein interactions in signaling pathways that are triggered by protein tyrosine kinases. The SH2 domain, a protein module of around 100 amino acids, is present in tyrosine kinase targets within the cell. SH2 domains are recruited to activated and autophosphorylated growth factor receptors by directly recognizing tyrosine phosphorylation sites. Growth factor receptors and other phosphoproteins have short phosphotyrosine (pTyr)-containing sequences that are bound by SH2 domains. The SH3 domain, a distinct element of approximately 50 residues that recognizes proline-rich and hydrophobic-amino-acid-containing regions, is frequently found in SH2-containing proteins. Tyrosine kinases can be coupled to downstream targets with SH3-binding sites by proteins with SH2 and SH3 domains acting as adaptors. These intricate and precise biochemical signaling pathways result in the regulation of gene expression, cytoskeletal architecture, and cell metabolism. The role of SH2/SH3 proteins in T cell signaling will be discussed. A special focus will be on the role of the hematopoietic signal transducer with SH2/SH3 domains, Vav1, in health and cancer.
正常细胞的生长和分化由蛋白酪氨酸激酶控制,蛋白酪氨酸激酶作为多种外部信号的受体。称为Src同源性2(SH2)和SH3结构域的小蛋白质模块介导由蛋白质酪氨酸激酶触发的信号通路中的蛋白质-蛋白质相互作用。SH2结构域是一种约100个氨基酸的蛋白质模块,存在于细胞内的酪氨酸激酶靶标中。SH2结构域通过直接识别酪氨酸磷酸化位点被募集到活化和自磷酸化的生长因子受体。生长因子受体和其他磷蛋白具有通过SH2结构域结合的短磷酸酪氨酸(pTyr)序列。SH3结构域是一种由大约50个残基组成的独特元件,识别富含脯氨酸和疏水性氨基酸的区域,经常在含有SH2的蛋白质中发现。酪氨酸激酶可以通过具有SH2和SH3结构域作为衔接子的蛋白质与具有SH3结合位点的下游靶标偶联。这些复杂而精确的生物化学信号通路导致基因表达、细胞骨架结构和细胞代谢的调节。SH2/SH3蛋白在T细胞信号传导中的作用将进行讨论。特别关注具有SH2/SH3结构域Vav1的造血信号转换器在健康和癌症中的作用。
{"title":"Role of Vav1, a hematopoietic signal transduction molecule, as an adaptor protein in health and disease","authors":"S. Katzav","doi":"10.37349/ei.2023.00095","DOIUrl":"https://doi.org/10.37349/ei.2023.00095","url":null,"abstract":"The growth and differentiation of normal cells are controlled by protein-tyrosine kinases, which serve as receptors for a wide variety of external signals. Small protein modules called Src homology 2 (SH2) and SH3 domains mediate protein-protein interactions in signaling pathways that are triggered by protein tyrosine kinases. The SH2 domain, a protein module of around 100 amino acids, is present in tyrosine kinase targets within the cell. SH2 domains are recruited to activated and autophosphorylated growth factor receptors by directly recognizing tyrosine phosphorylation sites. Growth factor receptors and other phosphoproteins have short phosphotyrosine (pTyr)-containing sequences that are bound by SH2 domains. The SH3 domain, a distinct element of approximately 50 residues that recognizes proline-rich and hydrophobic-amino-acid-containing regions, is frequently found in SH2-containing proteins. Tyrosine kinases can be coupled to downstream targets with SH3-binding sites by proteins with SH2 and SH3 domains acting as adaptors. These intricate and precise biochemical signaling pathways result in the regulation of gene expression, cytoskeletal architecture, and cell metabolism. The role of SH2/SH3 proteins in T cell signaling will be discussed. A special focus will be on the role of the hematopoietic signal transducer with SH2/SH3 domains, Vav1, in health and cancer.","PeriodicalId":93552,"journal":{"name":"Exploration of immunology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42872837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemokine-targeted nanoparticles: stimulation of the immune system in cancer immunotherapy 化学动力学靶向纳米粒子:癌症免疫疗法对免疫系统的刺激
Pub Date : 2023-04-27 DOI: 10.37349/ei.2023.00093
Ranjeet Singh, Prateek Srivastava, P. Manna
Surgery, chemotherapy, radiation therapy, and immunotherapy are potential therapeutic choices for many malignant and metastatic cancers. Despite adverse side effects and pain, surgery and chemotherapy continue to be the most common cancer treatments. However, patients treated with immunotherapy had better cancer control than those who got other treatments. There are two methods to activate immunological pathways: systemically and locally. To modify the tumor microenvironment (TME), the former uses systemic cytokine/chemokine (CK) delivery, whilst the latter uses immunological checkpoints or small molecule inhibitors. Organic and inorganic nanomaterials (NMs) enhanced the efficacy of cancer immunotherapy. NMs can transmit drugs, peptides, antigens, antibodies, whole cell membranes, etc. Surface-modified NMs precisely target and enter the tissues. The inner core of surface-modified NMs is composed of chemicals with limited bioavailability and biocompatibility, resulting in prolonged blood retention and decreased renal clearance. These platforms hinder or prevent many immune cell activities and modify the TME, enhancing the efficiency of cancer immunotherapy. By inhibiting CK/CK receptor signaling, cell migration and other immune responses could be controlled. Developing CK-targeted nanoparticles (NPs) that inhibit CK signaling or take advantage of the ligand-receptor connection is possible. Surface chemical modification of NMs with CKs or specific peptides has several medicinal applications, including tissue-specific drug delivery and limited cell migration in cancer-afflicted conditions. This review covers current developments in the role of different groups of CK-loaded NP in tumor therapy targeting immune cells and cancer. It also covers the role of NP targeting CK signaling which aids in immunogenic cell death (ICD) and induction of antitumor immunity. In addition, CK gene silencing and its capacity to prevent cancer metastasis as well as inhibition of immune cell migration to modulate the TME are discussed.
手术、化疗、放射治疗和免疫疗法是许多恶性和转移性癌症的潜在治疗选择。尽管有副作用和疼痛,但手术和化疗仍然是癌症最常见的治疗方法。然而,接受免疫治疗的患者比接受其他治疗的患者更好地控制了癌症。激活免疫途径有两种方法:全身和局部。为了改变肿瘤微环境(TME),前者使用系统性细胞因子/趋化因子(CK)递送,而后者使用免疫检查点或小分子抑制剂。有机和无机纳米材料(NMs)增强了癌症免疫疗法的疗效。NMs可以传输药物、肽、抗原、抗体、全细胞膜等。表面修饰的NMs精确靶向并进入组织。表面改性NMs的内核由生物利用度和生物相容性有限的化学物质组成,导致血液滞留时间延长和肾清除率降低。这些平台阻碍或阻止许多免疫细胞活动并修饰TME,提高癌症免疫疗法的效率。通过抑制CK/CK受体信号传导,可以控制细胞迁移和其他免疫反应。开发抑制CK信号传导或利用配体-受体连接的CK靶向纳米颗粒(NP)是可能的。CKs或特异性肽对NMs的表面化学修饰具有多种医学应用,包括组织特异性药物递送和在癌症相关条件下限制细胞迁移。本文综述了不同组CK-负载NP在靶向免疫细胞和癌症的肿瘤治疗中的作用的最新进展。它还涵盖了NP靶向CK信号传导的作用,该信号传导有助于免疫原性细胞死亡(ICD)和诱导抗肿瘤免疫。此外,还讨论了CK基因沉默及其预防癌症转移的能力,以及抑制免疫细胞迁移以调节TME的能力。
{"title":"Chemokine-targeted nanoparticles: stimulation of the immune system in cancer immunotherapy","authors":"Ranjeet Singh, Prateek Srivastava, P. Manna","doi":"10.37349/ei.2023.00093","DOIUrl":"https://doi.org/10.37349/ei.2023.00093","url":null,"abstract":"Surgery, chemotherapy, radiation therapy, and immunotherapy are potential therapeutic choices for many malignant and metastatic cancers. Despite adverse side effects and pain, surgery and chemotherapy continue to be the most common cancer treatments. However, patients treated with immunotherapy had better cancer control than those who got other treatments. There are two methods to activate immunological pathways: systemically and locally. To modify the tumor microenvironment (TME), the former uses systemic cytokine/chemokine (CK) delivery, whilst the latter uses immunological checkpoints or small molecule inhibitors. Organic and inorganic nanomaterials (NMs) enhanced the efficacy of cancer immunotherapy. NMs can transmit drugs, peptides, antigens, antibodies, whole cell membranes, etc. Surface-modified NMs precisely target and enter the tissues. The inner core of surface-modified NMs is composed of chemicals with limited bioavailability and biocompatibility, resulting in prolonged blood retention and decreased renal clearance. These platforms hinder or prevent many immune cell activities and modify the TME, enhancing the efficiency of cancer immunotherapy. By inhibiting CK/CK receptor signaling, cell migration and other immune responses could be controlled. Developing CK-targeted nanoparticles (NPs) that inhibit CK signaling or take advantage of the ligand-receptor connection is possible. Surface chemical modification of NMs with CKs or specific peptides has several medicinal applications, including tissue-specific drug delivery and limited cell migration in cancer-afflicted conditions. This review covers current developments in the role of different groups of CK-loaded NP in tumor therapy targeting immune cells and cancer. It also covers the role of NP targeting CK signaling which aids in immunogenic cell death (ICD) and induction of antitumor immunity. In addition, CK gene silencing and its capacity to prevent cancer metastasis as well as inhibition of immune cell migration to modulate the TME are discussed.","PeriodicalId":93552,"journal":{"name":"Exploration of immunology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46938746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mesenchymal stem cells—the master immunomodulators 间充质干细胞——主要的免疫调节剂
Pub Date : 2023-04-27 DOI: 10.37349/ei.2023.00092
Mehak Vohra, S. Arora
Mesenchymal stem/stromal cells (MSCs) are known as multipotent cells due to their ability to differentiate into various cell lineages of mesoderm origin. Recent developments in stem cell biology have provided a new ray of hope for the treatment of diseases and disorders that are yet to be treated. These cells have been widely used in animals and clinical trials in humans. To date, there are more than 920 clinical trials on humans related to MSCs as cell-based therapy in various conditions. The purpose of this review is to provide a summary of the characteristics of MSCs, evaluate their immunological properties, activation of MSCs that dictate their soluble factors, possible pathway, and mechanisms involved by MSCs and immune cell interaction, and various application of MSCs in different diseases.
间充质干/基质细胞(MSCs)被称为多能细胞,因为它们能够分化为中胚层来源的各种细胞谱系。干细胞生物学的最新发展为治疗尚未治疗的疾病和病症提供了新的希望。这些细胞已被广泛用于动物和人类的临床试验。迄今为止,已有920多项与MSCs在各种条件下作为细胞治疗相关的人类临床试验。本文综述了间充质干细胞的特征,评价了其免疫特性、决定其可溶性因子的间充质细胞的活化、可能的途径、间充质红细胞与免疫细胞相互作用的机制,以及间充质基质干细胞在不同疾病中的各种应用。
{"title":"Mesenchymal stem cells—the master immunomodulators","authors":"Mehak Vohra, S. Arora","doi":"10.37349/ei.2023.00092","DOIUrl":"https://doi.org/10.37349/ei.2023.00092","url":null,"abstract":"Mesenchymal stem/stromal cells (MSCs) are known as multipotent cells due to their ability to differentiate into various cell lineages of mesoderm origin. Recent developments in stem cell biology have provided a new ray of hope for the treatment of diseases and disorders that are yet to be treated. These cells have been widely used in animals and clinical trials in humans. To date, there are more than 920 clinical trials on humans related to MSCs as cell-based therapy in various conditions. The purpose of this review is to provide a summary of the characteristics of MSCs, evaluate their immunological properties, activation of MSCs that dictate their soluble factors, possible pathway, and mechanisms involved by MSCs and immune cell interaction, and various application of MSCs in different diseases.","PeriodicalId":93552,"journal":{"name":"Exploration of immunology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42109290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Exploration of immunology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1